Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients.

Coulthard, L R

Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients. [electronic resource] - Clinical and experimental immunology Oct 2012 - 36-46 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1365-2249

10.1111/j.1365-2249.2012.04626.x doi


Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antirheumatic Agents--therapeutic use
Arthritis, Rheumatoid--immunology
B-Lymphocytes--drug effects
CD4-Positive T-Lymphocytes--drug effects
CD8-Positive T-Lymphocytes--drug effects
Case-Control Studies
Disease Progression
Drug Therapy, Combination
Female
Flow Cytometry
GPI-Linked Proteins--immunology
Granulocytes--drug effects
Humans
Infliximab
Leukocyte Count
Leukocytes--drug effects
Lipopolysaccharide Receptors--immunology
Male
Methotrexate--administration & dosage
Methylprednisolone--therapeutic use
Middle Aged
Monocytes--drug effects
Receptors, IgG--immunology
Tumor Necrosis Factor-alpha--therapeutic use